The #LancetGateEffect Is Taking Names Before Kicking Ass – Please Contribute To The List

Things are happening faster than I expected.

Check this out.

We need to contribute to this effort.

Please dig up EVERY LINK that you can find of anti-HCQ and post it here. Be sure to include a description, including WHO exactly is referenced, to save people time when they go through comments.

Also, I highly recommend SCREENSHOTS, ARCHIVES, etc., and please provide LINKS to any screenshots or archives.

I would love for this blog to be a major contributor to the list of WHO (pun NOW intended) is responsible for anti-HCQ treachery.

Even if somebody is just repeating propaganda, it may help lead back to the source.

Leads are fine, as well as PROOFS.


116 thoughts on “The #LancetGateEffect Is Taking Names Before Kicking Ass – Please Contribute To The List

  1. “Please dig up EVERY LINK that you can find of anti-HCQ and post it here.”


    That may be a little more difficult than it sounds, for the simple reason that I suspect most people saved and bookmarked information that supported the pro-HCQ argument, as opposed to saving the anti-HCQ propaganda.

    Liked by 6 people

  2. VA study


    French Doctor Didier Raoult Cites ‘Scientific Misconduct’ in Recent VA Study on Hydroxychloroquine; Two Major Flaws


    Liked by 7 people

  3. Lancet already cited. Below hits on NEJM. Same as Lancet? I dunno. Then a Brazil study nailed for administering lethal doses of HCQ. Hope someone is in jail over the latter. IF this is redundant information, apologies.


    Two studies, in Lancet and NEJM, were retracted because of questionable data. A study from Brazil, published in JAMA, is under investigation because researchers were giving patients lethal doses of chloroquine.


    Liked by 5 people

    1. On June 26, Episode 252 of Steve Bannon’s War Room had a call-in interview with pro-HCQ Dr. Paulo Zanotto from Brazil.

      Dr. Zanotto detailed the political situation in Brazil, that it is parallel to ours. There are states with Marxist state governments that hate Pres. Jair Bolsonaro, “the Trump of the Tropics”, and states with pro-Bolsonaro governments. The states with pro-Bolsonaro governments allow HCQ to be prescribed. The Marxist states oppose HCQ for treating CCP virus, and try to discredit it.

      The infamous Brazilian study you mention was done in one of the Marxist states, and the researchers evaded the normal requirement for human experimentation to run everything past the university ethics board in advance. Then they lied about that when audited, and pretended they had had ethics board approval. Now they are facing a homicide investigation, and possibly jail time, for the deaths of the patients to whom they gave lethal doses of HCQ.

      [Dr. Zanotto may have appeared on more than one episode. And right now I have technical difficulties downloading shows, so I can’t confirm that all the info above is in this episode.]

      Liked by 1 person

      1. Best part is, President Trump knows. As does one of his Killers, Navarro. President Trump gets reelected, ChiComs will be toast. Chinee will pay the price. But, TDB. President Trump tried mightily to let everyone win, while maintaining America First. President Trump will go out of his way to screw ChiComs into oblivion. It may have been one of his goals and I didn’t see it. The oblivion aspect.

        Liked by 5 people

  4. FTA

    Three big studies dim hopes that hydroxychloroquine can treat or prevent C


    Liked by 3 people

  5. FTA

    Hydroxychloroquine: First Large Study Does Not Support Routine Use in COVID-19 Patients


    Liked by 3 people

  6. If you search (I used DDG) for hydroxychloroquine doesn’t work, you will get pages of articles that say it doesn’t work. I’m not in a situation right now where I can follow up on that.

    Liked by 4 people

  7. Study shows hydroxychloroquine’s harmful effects on heart rhythm

    Date: June 1, 2020
    Source: Georgia Institute of Technology
    Summary: The malaria drug hydroxychloroquine, which has been promoted as a potential treatment for Covid-19, is known to have potentially serious effects on heart rhythms. Now, a team of researchers has used an optical mapping system to observe exactly how the drug creates serious disturbances in the electrical signals that govern heartbeat.

    Fenton and his colleagues have already begun a new study to evaluate the effects of HCQ with the antibiotic azithromycin, which has been suggested as a companion treatment. Azithromycin can also cause the long QT effect, potentially increasing the impact on Covid-19 patients.

    The study, which was supported by grants from the National Institutes of Health and National Science Foundation, was also coauthored by Dr. Hiroshi Ashikaga from Johns Hopkins University School of Medicine; Dr. Neal Bathia from the Division of Cardiology, Section of Electrophysiology at Emory University Hospital; Conner Herndon, Abouzar Kaboudian, and James C. Gumbart from the Georgia Tech School of Physics, and Elizabeth Cherry from the Georgia Tech School of Computational Science and Engineering.

    Liked by 4 people

  8. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems: Does not affect FDA-approved uses for malaria, lupus, and rheumatoid arthritis

    July 1, 2020 Update: A summary of the FDA review of safety issues with the use of hydroxychloroquine and chloroquine to treat hospitalized patients with COVID-19 is now available. This includes reports of serious heart rhythm problems and other safety issues, including blood and lymph system disorders, kidney injuries, and liver problems and failure.

    June 15, 2020 Update: Based on ongoing analysis and emerging scientific data, FDA has revoked the emergency use authorization (EUA) to use hydroxychloroquine and chloroquine to treat COVID-19 in certain hospitalized patients when a clinical trial is unavailable or participation is not feasible. We made this determination based on recent results from a large, randomized clinical trial in hospitalized patients that found these medicines showed no benefit for decreasing the likelihood of death or speeding recovery. This outcome was consistent with other new data, including those showing the suggested dosing for these medicines are unlikely to kill or inhibit the virus that causes COVID-19. As a result, we determined that the legal criteria for the EUA are no longer met. Please refer to the Revocation of the EUA Letter and FAQs on the Revocation of the EUA for Hydroxychloroquine Sulfate and Chloroquine Phosphate for more information.

    Liked by 5 people

    1. Excellent. This shows that the FDA saboteurs allied with LancetGates were still pushing the lies OVER TWO WEEKS after Switzerland had reversed course over LancetGate retraction and/or increased deaths. Somebody at FDA was pretending not to know – likely setting up Trump’s appointee Hahn, who is an outsider and trial doc. I think he’s supposed to be a casualty.

      Gail’s theory of a TRAP for Trump is making sense. They pull one way or the other and try to get him off balance.

      Liked by 7 people

  9. Every one of these has either a headline that claims HCQ is ineffective, a quote or “study” claiming it doesn’t work, Dr.’s claiming the same, or information that somehow Trump was promoting a “fake” cure:

    NIH halts clinical trial of hydroxychloroquine. Study shows treatment does no harm, but provides no benefit:

    Dr. Tim Morris; Dr. Martin Landry; Dr. David Boulware of the University of Minnesota-Twin Cities; Gilead; Eric Topol, director of the Scripps Research Translational Institute:

    “massive trial in the UK called Randomised Evaluation of Covid-19 Therapy, or “Recovery,” Martin Landray, a physician and researcher in the University of Oxford’s Nuffield Department of Population Health, Dr. David Boulware, Nahid Bhadelia, medical director of the Special Pathogens Unit at Boston Medical Center, Bob Wachter, chair of the department of medicine at UC San Francisco:

    Eric Topol, director of the Scripps Translational Science Institute. U.S.; Peter Kremsner of the University of Tübingen; Nahid Bhadelia, a physician at Boston Medical Center; Martin Landray of the University of Oxford; Dr. Boulware again; Oriol Mitjà of the Germans Trias i Pujol University Hospital

    Daniel S. Budnitz, MD, MPH, of the Centers for Disease Control and Prevention;

    Richard Louis Kravitz, M.D., M.S.P.H.,Professor of Internal Medicine, University of California Davis;

    Dr Anthony Fauci

    Dr. Peter Lurie, the president of the Center for Science in the Public Interest; Rick Bright

    Dr. David Boulware, AGAIN:

    Researchers at the University of Albany; Camela Thompson, a freelance writer based in the Seattle area:

    Eric A Meyerowitz, Augustin G L Vannier, Morgan G N Friesen, Sara Schoenfeld, Jeffrey A Gelfand, Michael V Callahan, Arthur Y Kim, Patrick M Reeves, Mark C Poznansky:

    Retracted Lancet article:

    Andrew Solender, Forbes Staff:

    Liked by 7 people

  10. The first four studies tested HCQ or HCQ with AZ, but none included zinc and were basically inconclusive. The last two references talk about the retraction of the Lancet study.

    13. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020:105949. doi: 10.1016/j.ijantimicag.2020.105949 [published Online First: 2020/03/25]
    14. Tang W, Cao Z, Han M, et al. Hydroxychloroquine in patients mainly with mild to moderate COVID-19: an open-label, randomized, controlled trial. medRxiv 2020:2020.04.10.20060558. doi: 10.1101/2020.04.10.20060558
    15. Chen J, Liu D, Liu L, et al. [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]. Zhejiang Da Xue Xue Bao Yi Xue Ban 2020;49(2):215-19. [published Online First: 2020/05/12]
    16. Mahevas M, Tran V-T, Roumier M, et al. No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial. medRxiv 2020:2020.04.10.20060699. doi: 10.1101/2020.04.10.20060699

    17. Mehra MR, Ruschitzka F, Patel AN. Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet doi: 10.1016/S0140-6736(20)31324-6
    18. The Lancet E. Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet doi: 10.1016/S0140-6736(20)31290-3

    Liked by 4 people

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s